United States · FDA National Drug Code directory

APREPITANT

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
13668-591_d61cf041-fb75-4b56-949d-1f2f93acf4d0
Product NDC
13668-591
Form
CAPSULE
Composition / generic term
APREPITANT
Labeler
Torrent Pharmaceuticals Limited
Marketing category
ANDA
Marketing start / end (source format)
20201021
Source listing expiry
20271231

Source-listed ingredients

  • APREPITANT — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (13668-591-81) / 1 CAPSULE in 1 BLISTER PACK (13668-591-80) · 13668-591-81
  • 5 BLISTER PACK in 1 CARTON (13668-591-82) / 1 CAPSULE in 1 BLISTER PACK (13668-591-80) · 13668-591-82

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
APREPITANT — United States | Molindra Medicines